Worldwide: Licensing & Syndication

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
From License To Launch: Six Lessons For Developers Building Games Based On Third-Party IP
Navigating the complex legal landscape of licensed video games requires careful attention to intellectual property rights, approval processes, and revenue structures. From understanding what's actually included in a license to planning for the end of a licensing term, game developers face unique challenges when adapting existing franchises that don't exist with original IP.
United States IP
FK
Frankfurt Kurnit Klein & Selz
Video
The Patent Enforcement Economy Is Leaving Inventors Behind/ IPWatchdog Unleashed (Video)
The patent system promises inventors exclusive rights in exchange for public disclosure, but enforcement has become prohibitively expensive, creating a minimum damages threshold that effectively rations access to justice. Litigation finance and contingency arrangements have emerged not as exploitation but as necessary responses to a system where defending patent rights can cost $12-20 million, making infringement economically rational even when patents are strong.
United States IP
LA
Licks Attorneys
Article
Teva And Polpharma Biologics Announce Global Licensing Agreement For Ocrelizumab Biosimilar For Multiple Sclerosis
Teva Pharmaceuticals and Polpharma Biologics have entered into a global licensing agreement for the commercialization of a biosimilar candidate to Genentech's OCREVUS (ocrelizumab), a treatment for multiple sclerosis. The agreement combines Polpharma Biologics' development expertise with Teva's commercial capabilities across major markets including the United States, Europe, and several other territories. Under the terms, Polpharma Biologics will handle development and manufacturing while Teva manages regul
United States Healthcare
GP
Goodwin Procter LLP
Article
Non-U.S. Trademark Registrants Beware!
When a non-U.S. company obtains a U.S. trademark registration based on a foreign registration without U.S. use, failing to file the required Declaration of Use within six years can result in cancellation with serious consequences. A recent TTAB decision demonstrates how a lapsed registration loses all protective value, even against later-filed confusingly similar marks that were registered while the original registration was still active.
United States IP
CL
Cowan Liebowitz & Latman PC
Article
A New Framework For AI Permissions In Entertainment: RSL Media’s Human Consent Standard
RSL Media has introduced the Human Consent Standard, a machine-readable protocol allowing individuals to declare whether AI systems may use their creative works, identity, likeness, voice, characters, or marks. While endorsed by major entertainment industry figures and organizations, the voluntary standard's effectiveness depends on pending federal legislation like the NO FAKES Act, voluntary adoption by AI developers, and its ability to withstand contractual pressures that could undermine its protective fu
United States IP
GA
Global Advertising Lawyers Alliance (GALA)
Article
Intelligence Piracy: The Actor Who Was Never There
Artificial intelligence has created a new form of piracy in film and television, one that doesn't steal finished works but instead extracts the craft and identity of performers themselves. From synthetic actors like Tilly Norwood to unauthorized digital replicas of real stars, the industry faces a fundamental question: when AI learns to recreate a performer's face, voice, and mannerisms from their body of work, whose craft has been taken?
United States IP
R
Rouse
Article
Critical Considerations For AI Model Licensing Agreements In Healthcare
AI licensing in healthcare involves complex decisions about asset definition, control allocation, and accountability as models and data evolve. This white paper examines the practical contracting challenges that arise when AI models intersect with health data, exploring how organizations can structure agreements that account for messy datasets, model artifacts, and the reality that machine learning systems resist traditional ownership frameworks.
United States Healthcare
FH
Foley Hoag LLP
See more

Latest Videos

See more